In this report, the "United States Smart Insulin Pens Market" is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Smart insulin pens are connected insulin pens that are reusable and work with insulin cartridges. Some of the advantages of smart insulin pens include, automatic record of injected amount of insulin, no need of logs, reduced cases of accidental insulin stacking, and access to computer-generated reports.
Increasing prevalence of diabetes is a major factor boosting growth of the U.S. smart insulin pens market over the forecast period. For instance, according to International Diabetes Federation’s IDF Diabetes Atlas 2019 Edition, the numbers of adults with diabetes in the U.S. was 31.0 million. Moreover, increasing initiatives of government and private organizations for the treatment for diabetes in low- and middle-income countries is also expected to offer lucrative growth opportunities for players in the U.S. smart insulin pens market. For instance, in November 2019, The World Health Organization (WHO) announced the start of a pilot program to prequalify human insulin to increase treatment for diabetes in low- and middle-income countries.
Increasing geriatric population susceptible to diabetes is expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, geriatric population in the U.S. is expected to reach 77 million by 2035. Moreover, increasing demand for self-injection devices and accuracy in dosage delivery of insulin is also contributing to growth of the market.
However, restricted usage of smart insulin pens in patients that require a combination of two types of insulin is expected to hamper growth of the U.S. smart insulin pens market.
Key players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio. For instance, in June 2019, Companion Medical, Inc. collaborated with DexCom, Inc. to enable a direct exchange of CGM data from Dexcom with insulin data from InPen into both companies’ software applications. Similarly, in December 2019, BIOCORP, a medical devices and smart drug delivery systems developer based in France, partnered with SANOFI for the use of Mallya technology, a connected device for insulin pens.
Key Takeaways:
• Increasing prevalence of diabetes is expected to augment growth of the U.S. smart insulin pens market
• Restricted usage of smart insulin pens in patients that require a combination of two types of insulin is expected to hamper growth of the market
• Major players operating in the U.S. smart insulin pens market include Companion Medical, Inc., BIOCORP, Novo Nordisk, Sanofi Diabetes, Medtronic, plc., BD, Animas, Roche, Insulet, Bomtech, BioSampling, Cardiocomm Solutions, Henke-Sass, Kavo, Megasan Medical, Nipro, Mika Medical, Rudolf Riester, and Smiths Medical.
Geographically, this report splits the United States market into seven regions:
- The West
- Southwest
- The Middle Atlantic
- New England
- The South
- The Midwest
with sales (volume), revenue (value), market share and growth rate of Smart Insulin Pens in these regions, from 2014 to 2025 (forecast).
United States Smart Insulin Pens market competition by top manufacturers/players, with Smart Insulin Pens sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
* Novo Nordisk
* Sanofi Diabetes
* Medtronic
* BD
* Animas
* Roche
* Insulet
* Bomtech
* BioSampling
* Cardiocomm Solutions
* Henke-Sass
* Kavo
* Megasan Medical
* Nipro
* Mika Medical
* Rudolf Riester
* Smiths Medical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
- Bluetooth Connected Smart Insulin Pens
- USB Connected Smart Insulin Pens
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Smart Insulin Pens for each application, including
- Clinics and Ambulatory Surgical Centres
- e-Commerce
- Retail Pharmacies
*** If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Smart Insulin Pens Market Report 2019
1 Smart Insulin Pens Overview
1.1 Product Overview and Scope of Smart Insulin Pens
1.2 Classification of Smart Insulin Pens by Product Category
1.2.1 United States Smart Insulin Pens Market Size (Sales Volume) Comparison by Type (2014-2025)
1.2.2 United States Smart Insulin Pens Market Size (Sales Volume) Market Share by Type (Product Category) in 2018
1.2.3 Bluetooth Connected Smart Insulin Pens
1.2.4 USB Connected Smart Insulin Pens
1.3 United States Smart Insulin Pens Market by Application/End Users
1.3.1 United States Smart Insulin Pens Market Size (Consumption) and Market Share Comparison by Application (2014-2025)
1.3.2 Clinics and Ambulatory Surgical Centres
1.3.3 e-Commerce
1.3.4 Retail Pharmacies
1.4 United States Smart Insulin Pens Market by Region
1.4.1 United States Smart Insulin Pens Market Size (Value) Comparison by Region (2014-2025)
1.4.2 The West Smart Insulin Pens Status and Prospect (2014-2025)
1.4.3 Southwest Smart Insulin Pens Status and Prospect (2014-2025)
1.4.4 The Middle Atlantic Smart Insulin Pens Status and Prospect (2014-2025)
1.4.5 New England Smart Insulin Pens Status and Prospect (2014-2025)
1.4.6 The South Smart Insulin Pens Status and Prospect (2014-2025)
1.4.7 The Midwest Smart Insulin Pens Status and Prospect (2014-2025)
1.5 United States Market Size (Value and Volume) of Smart Insulin Pens (2014-2025)
1.5.1 United States Smart Insulin Pens Sales and Growth Rate (2014-2025)
1.5.2 United States Smart Insulin Pens Revenue and Growth Rate (2014-2025)
2 United States Smart Insulin Pens Market Competition by Players/Suppliers
2.1 United States Smart Insulin Pens Sales and Market Share of Key Players/Suppliers (2014-2019)
2.2 United States Smart Insulin Pens Revenue and Share by Players/Suppliers (2014-2019)
2.3 United States Smart Insulin Pens Average Price by Players/Suppliers (2014-2019)
2.4 United States Smart Insulin Pens Market Competitive Situation and Trends
2.4.1 United States Smart Insulin Pens Market Concentration Rate
2.4.2 United States Smart Insulin Pens Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Smart Insulin Pens Manufacturing Base Distribution, Sales Area, Product Type
3 United States Smart Insulin Pens Sales (Volume) and Revenue (Value) by Region (2014-2019)
3.1 United States Smart Insulin Pens Sales and Market Share by Region (2014-2019)
3.2 United States Smart Insulin Pens Revenue and Market Share by Region (2014-2019)
3.3 United States Smart Insulin Pens Price by Region (2014-2019)
4 United States Smart Insulin Pens Sales (Volume) and Revenue (Value) by Type (Product Category) (2014-2019)
4.1 United States Smart Insulin Pens Sales and Market Share by Type (Product Category) (2014-2019)
4.2 United States Smart Insulin Pens Revenue and Market Share by Type (2014-2019)
4.3 United States Smart Insulin Pens Price by Type (2014-2019)
4.4 United States Smart Insulin Pens Sales Growth Rate by Type (2014-2019)
5 United States Smart Insulin Pens Sales (Volume) by Application (2014-2019)
5.1 United States Smart Insulin Pens Sales and Market Share by Application (2014-2019)
5.2 United States Smart Insulin Pens Sales Growth Rate by Application (2014-2019)
5.3 Market Drivers and Opportunities
6 United States Smart Insulin Pens Players/Suppliers Profiles and Sales Data
6.1 Novo Nordisk
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Smart Insulin Pens Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Novo Nordisk Smart Insulin Pens Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Sanofi Diabetes
6.2.2 Smart Insulin Pens Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sanofi Diabetes Smart Insulin Pens Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Medtronic
6.3.2 Smart Insulin Pens Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Medtronic Smart Insulin Pens Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 BD
6.4.2 Smart Insulin Pens Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 BD Smart Insulin Pens Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 Animas
6.5.2 Smart Insulin Pens Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Animas Smart Insulin Pens Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 Roche
6.6.2 Smart Insulin Pens Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Roche Smart Insulin Pens Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 Insulet
6.7.2 Smart Insulin Pens Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Insulet Smart Insulin Pens Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
6.8 Bomtech
6.8.2 Smart Insulin Pens Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bomtech Smart Insulin Pens Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Main Business/Business Overview
6.9 BioSampling
6.9.2 Smart Insulin Pens Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 BioSampling Smart Insulin Pens Sales, Revenue, Price and Gross Margin (2014-2019)
6.9.4 Main Business/Business Overview
6.10 Cardiocomm Solutions
6.10.2 Smart Insulin Pens Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Cardiocomm Solutions Smart Insulin Pens Sales, Revenue, Price and Gross Margin (2014-2019)
6.10.4 Main Business/Business Overview
6.11 Henke-Sass
6.12 Kavo
6.13 Megasan Medical
6.14 Nipro
6.15 Mika Medical
6.16 Rudolf Riester
6.17 Smiths Medical
7 Smart Insulin Pens Manufacturing Cost Analysis
7.1 Smart Insulin Pens Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Smart Insulin Pens
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Smart Insulin Pens Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Smart Insulin Pens Major Manufacturers in 2018
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Smart Insulin Pens Market Size (Value and Volume) Forecast (2019-2025)
11.1 United States Smart Insulin Pens Sales Volume, Revenue Forecast (2019-2025)
11.2 United States Smart Insulin Pens Sales Volume Forecast by Type (2019-2025)
11.3 United States Smart Insulin Pens Sales Volume Forecast by Application (2019-2025)
11.4 United States Smart Insulin Pens Sales Volume Forecast by Region (2019-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Request Discount 
Inquire Before Buy
